Skip to main content

FDA recall, , Moderate risk

HCSC-Blood Center Plasma and Red Blood Cells

PF24 Plasma and Red Blood Cells, Leukocytes Reduced, with or without irradiation, were distributed after incomplete donor screening.

Recall ended Sep 23, 2026. Still check yours.

What happened

HCSC-Blood Center began a recall on May 29, 2025, of Red Blood Cells, Leukocytes Reduced, Irradiated; Red Blood Cells, Leukocytes Reduced; and PF24 Plasma, each one unit, because they were collected from a donor for whom donor eligibility screening was incomplete and were distributed. The FDA classified the recall on September 23, 2026, and the products were distributed in Pennsylvania.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

3 products

Compare these details with yours, then check the recall notice to see which units are recalled.

  1. Red Blood Cells, Leukocytes Reduced, Irradiated

    Reason: Red Blood Cells, Leukocytes Reduced, Irradiated, collected from a donor for whom donor eligibility screening was incomplete, were distributed.

  2. Red Blood Cells, Leukocytes Reduced

    Reason: Red Blood Cells, Leukocytes Reduced, collected from a donor for whom donor eligibility screening was incomplete, were distributed.

  3. PF24 Plasma

    Reason: PF24 Plasma, collected from a donor for whom donor eligibility screening was incomplete, was distributed.

Recall details

Company began the recall
Company
HCSC-Blood Center
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
99047
Recall numbers
B-0203-2026 to B-0205-2026

All recalls from HCSC-Blood Center

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA · Recall ended

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

Summary by Recall Canary, written with AI · summary updated Oct 23, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)